Treat Nicolas J, Smith Deedee, Teng Chengwen, Flores Joel D, Abel Brooks A, York Adam W, Huang Faqing, McCormick Charles L
Department of Polymer Science, University of Southern Mississippi 118 College Drive, Hattiesburg MS 39406.
ACS Macro Lett. 2012 Jan 17;1(1):100-104. doi: 10.1021/mz200012p. Epub 2011 Nov 21.
We report the synthesis and controlled radical homo- and block copolymerization of 3-guanidinopropyl methacrylamide (GPMA) utilizing aqueous reversible addition-fragmentation chain transfer (aRAFT) polymerization. The resulting homopolymer and block copolymer with N-(2-hydroxypropyl) methacrylamide (HPMA) were prepared to mimic the behavior of cell penetrating peptides (CPPs) and poly(arginine) (> 6 units) which have been shown to cross cell membranes. The homopolymerization mediated by 4-cyano-4-(ethylsulfanylthiocarbonylsulfanyl)pentanoic acid (CEP) in aqueous buffer exhibited pseudo-first-order kinetics and linear growth of molecular weight with conversion. Retention of the "living" thiocarbonylthio ω-end-group was demonstrated through successful chain extension of the GPMA macroCTA yielding GPMA(37)-b-GPMA(61) (M(w)/M(n) =1.05). Block copolymers of GPMA with the non-immunogenic, biocompatible HPMA were synthesized yielding HPMA(271)-b-GPMA(13) (M(w)/M(n) = 1.15). Notably, intracellular uptake was confirmed by fluorescence microscopy, confocal laser scanning microscopy, and flow cytometry experiments after 2.5 h incubation with KB cells at 4 °C and at 37 °C utilizing FITC-labeled, GPMA-containing copolymers. The observed facility of cellular uptake and the structural control afforded by aRAFT polymerization suggest significant potential for these synthetic (co)polymers as drug delivery vehicles in targeted therapies.
我们报道了利用水性可逆加成-断裂链转移(aRAFT)聚合反应合成3-胍基丙基甲基丙烯酰胺(GPMA)并进行可控自由基均聚和嵌段共聚。制备了所得的均聚物以及与N-(2-羟丙基)甲基丙烯酰胺(HPMA)的嵌段共聚物,以模拟已被证明可穿过细胞膜的细胞穿透肽(CPPs)和聚精氨酸(>6个单元)的行为。在水性缓冲液中由4-氰基-4-(乙基硫代硫羰基硫烷基)戊酸(CEP)介导的均聚反应呈现出准一级动力学,且分子量随转化率呈线性增长。通过成功地将GPMA大分子链转移剂(macroCTA)进行链延伸得到GPMA(37)-b-GPMA(61)(M(w)/M(n)=1.05),证明了“活性”硫代羰基硫ω-端基得以保留。合成了GPMA与非免疫原性、生物相容性的HPMA的嵌段共聚物,得到HPMA(271)-b-GPMA(13)(M(w)/M(n)=1.15)。值得注意的是,在4℃和37℃下与KB细胞孵育2.5小时后,利用异硫氰酸荧光素(FITC)标记的含GPMA共聚物,通过荧光显微镜、共聚焦激光扫描显微镜和流式细胞术实验证实了细胞内摄取。所观察到的细胞摄取便利性以及aRAFT聚合反应所提供的结构控制表明,这些合成(共)聚物作为靶向治疗中的药物递送载体具有巨大潜力。